ATR – aptargroup, inc. (US:NASDAQ)

News

AptarGroup CEO: China is unfazed by Trump's tariffs because their ‘grit and sheer willpower is on a different scale' [Yahoo! Finance]
AptarGroup, Inc. (NYSE:ATR) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? [Yahoo! Finance]
AptarGroup CEO: China is unfazed by Trump's tariffs because their ‘grit and sheer willpower is on a different scale' [Fortune]
Nasus Pharma CEO Issues 2025 Letter to Shareholders [Yahoo! Finance]
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com